David Y. Liu

David Y. Liu

Geen lopende functies

Vermogen: 4 M $ op 31-03-2024

73 jaar
Health Technology
Consumer Services

Profiel

David Y.
Liu
was the founder of Trenovus, Inc. (founded in 2010) where he held the title of Chief Operating Officer from 2010 to 2012.
He previously worked at Scios, Inc. from 1992 to 2002 as Director-Inflammation Research and at FibroGen, Inc. from 2002 to 2010 as Vice President-Research.
Dr. Liu also worked at Harvard Medical School from 1976 to 1986 as Assistant Professor-Medicine Department.
He is currently the Chief Research & Development Strategy Officer at Protagonist Therapeutics, Inc. (since 2013).
Dr. Liu holds a doctorate degree from Michigan State University and an undergraduate degree from The University of Chicago.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
15-03-2023 144 687 ( 0.25% ) 4 M $ 31-03-2024

Eerdere bekende functies van David Y. Liu

BedrijvenFunctieEinde
PROTAGONIST THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 01-01-2023
Trenovus, Inc. Founder 01-01-2012
FIBROGEN, INC. Chief Tech/Sci/R&D Officer 01-01-2010
Corporate Officer/Principal 01-01-2002
Harvard Medical School Corporate Officer/Principal 01-01-1986
Ervaring van David Y. Liu in detail bekijken

Opleiding van David Y. Liu

Michigan State University Doctorate Degree
The University of Chicago Undergraduate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van David Y. Liu in detail bekijken

Connecties

100 +

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven2
FIBROGEN, INC.

Health Technology

PROTAGONIST THERAPEUTICS, INC.

Health Technology

Bedrijven in privébezit2

Health Technology

Trenovus, Inc.

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. David Y. Liu